The Evolving Role of Genotypic Data

Ruben A. Mesa, MD

Video Categories: Myelofibrosis

Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.

November 19, 2014

Optimal Value-Based Therapy

Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.Supported through funding from Incyte

October 14, 2014

New Data Coming Out of ASCO

Hear Dr. Michaelis describe the new data coming out of ASCO regarding polycythemia vera including new medicine.Supported through funding from Incyte